tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Pfizer Inc (DE:PFE)
:PFE
Germany Market
PFE
Pfizer
RESEARCH TOOLSreports
Advertisement

Pfizer (PFE) Stock News & Sentiment

Compare
194 Followers
Pfizer’s Pediatric Ulcerative Colitis Study: A Potential Game-Changer
Premium
Company Announcements
Pfizer’s Pediatric Ulcerative Colitis Study: A Potential Game-Changer
17h ago
PFE
Pfizer’s Pediatric Migraine Study: A Potential Game-Changer for Rimegepant
Premium
Company Announcements
Pfizer’s Pediatric Migraine Study: A Potential Game-Changer for Rimegepant
17h ago
PFE
Pfizer’s Ponsegromab Study: A Potential Game-Changer in Pancreatic Cancer Treatment
Premium
Company Announcements
Pfizer’s Ponsegromab Study: A Potential Game-Changer in Pancreatic Cancer Treatment
17h ago
PFE
Pfizer’s New Study on Ritlecitinib: A Potential Game-Changer for Chronic Urticaria?
Premium
Company Announcements
Pfizer’s New Study on Ritlecitinib: A Potential Game-Changer for Chronic Urticaria?
17h ago
PFE
Pfizer’s Promising Phase 3 Study on Prostate Cancer Treatment: A Market Game-Changer?
Premium
Company Announcements
Pfizer’s Promising Phase 3 Study on Prostate Cancer Treatment: A Market Game-Changer?
17h ago
PFE
Pfizer’s Latest Clinical Trial: A New Hope for Prostate Cancer Treatment
Premium
Company Announcements
Pfizer’s Latest Clinical Trial: A New Hope for Prostate Cancer Treatment
17h ago
PFE
Pfizer’s New Phase 3 Study: A Potential Game-Changer for COVID-19 Treatment in Immunocompromised Adults
Premium
Company Announcements
Pfizer’s New Phase 3 Study: A Potential Game-Changer for COVID-19 Treatment in Immunocompromised Adults
17h ago
PFE
More DE:PFE News >

PFE News on the Web

Pfizer’s Marstacimab Study: A Potential Game-Changer for Hemophilia Treatment
TipRanks News
Neutral
Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?
Zacks
Neutral
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
InvestorsHub
Neutral
3 Healthcare Stocks Paying the Highest Dividends of 2025
The Motley Fool
Neutral
Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever.
The Motley Fool
Neutral
2 Unstoppable Dividend Stocks Yielding More Than 4% That Income-Seeking Investors Will Want to Buy in November and Hold Forever
The Motley Fool
Neutral
What Occidental Petroleum’s Latest Backer Sees in Oil’s Next Chapter
The Motley Fool
Neutral
PFE versus BMY: Which Large Oncology Drugmaker Is a Better Pick Now?
Zacks
Neutral

News Score - Last 7 Days

Neutral
DE:PFE
Sector Average
Media Buzz
This Week15 articles
Weekly Average27.75 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:PFE’s Media Buzz Sentiment?
15 articles about DE:PFE were published this week. In an average week, 27.75 articles are published.
    What is DE:PFE’s weekly average amount of articles?
    In an average week, 27.75 articles about DE:PFE are published.
      What is DE:PFE’s News Sentiment?
      59% of articles about DE:PFE were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        RNAAvidity Biosciences
        ALKSAlkermes
        NBIXNeurocrine
        ISRGIntuitive Surgical
        EHCEncompass Health
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing